Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia
Authors
Keywords
-
Journal
CLINICAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-11-24
DOI
10.1093/clinchem/hvac200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing
- (2022) Fan Jiang et al. GENE
- Early genetic screening uncovered a high prevalence of thalassemia among 18,309 neonates in Guizhou, China
- (2021) Mei Tan et al. CLINICAL GENETICS
- A More Universal Approach to Comprehensive Analysis of Thalassemia Alleles (CATSA)
- (2021) Qiaowei Liang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Molecular Characterization of α- and β-Thalassaemia Among Children From 1 to 10 Years of Age in Guangxi, A Multi-Ethnic Region in Southern China
- (2021) Sheng He et al. Frontiers in Pediatrics
- The value of single-molecule real-time technology in the diagnosis of rare thalassemia variants and analysis of phenotype–genotype correlation
- (2021) Shiqiang Luo et al. JOURNAL OF HUMAN GENETICS
- Long molecule sequencing: a new approach for identification of clinically significant DNA variants in alpha and beta thalassemia carriers
- (2020) Liangpu Xu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Molecular epidemiological and hematological profile of thalassemia in the Dongguan Region of Guangdong Province, Southern China
- (2020) Qi Peng et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- The carriage rates of αααanti3.7, αααanti4.2, and HKαα in the population of Guangxi, China measured using a rapid detection qPCR system to determine CNV in the α-globin gene cluster
- (2020) Ju Long et al. GENE
- Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou Region, P.R. China
- (2019) Haoqing Zhang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Prenatal and preimplantation diagnosis of hemoglobinopathies
- (2018) C. Vrettou et al. International Journal of Laboratory Hematology
- Thalassaemia
- (2018) Ali T Taher et al. LANCET
- Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China
- (2017) Jing He et al. GENETICS IN MEDICINE
- Pre Gestational Thalassemia Screening in Mainland China: The First Two Years of a Preventive Program
- (2017) Fan Jiang et al. HEMOGLOBIN
- Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies
- (2017) Xuan Shang et al. EBioMedicine
- EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies
- (2015) Joanne Traeger-Synodinos et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The spectrum of α- and β-thalassemia mutations of the Li people in Hainan Province of China
- (2014) Hongxia Yao et al. BLOOD CELLS MOLECULES AND DISEASES
- The Prevalence and Molecular Spectrum of α- and β-Globin Gene Mutations in 14,332 Families of Guangdong Province, China
- (2014) Aihua Yin et al. PLoS One
- World Distribution, Population Genetics, and Health Burden of the Hemoglobinopathies
- (2013) T. N. Williams et al. Cold Spring Harbor Perspectives in Medicine
- Thalassaemia
- (2011) Douglas R Higgs et al. LANCET
- Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China
- (2010) F Xiong et al. CLINICAL GENETICS
- Global epidemiology of haemoglobin disorders and derived service indicators
- (2008) Bernadette Modell BULLETIN OF THE WORLD HEALTH ORGANIZATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started